JOHN HOPE FRANKLIN CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Psychology of Minimally Invasive Surgical Scars
Not Applicable
Terminated
- Conditions
- Obesity
- Interventions
- Procedure: Standard Laparoscopic ApproachProcedure: Percutaneous Approach
- First Posted Date
- 2016-12-29
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- Duke University
- Target Recruit Count
- 32
- Registration Number
- NCT03004560
- Locations
- 🇺🇸
Duke Center for Metabolic and Weight Loss Surgery, Durham, North Carolina, United States
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Not Applicable
Completed
- Conditions
- ObesityNutrition DisordersOverweightSigns and SymptomsOvernutrition
- Interventions
- Behavioral: Intervention Program
- First Posted Date
- 2016-12-28
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Duke University
- Target Recruit Count
- 443
- Registration Number
- NCT03003403
- Locations
- 🇺🇸
Duke University - with Piedmont Health Services, Inc., Durham, North Carolina, United States
Neurocognition, Lifestyle Modification, and Treatment Resistant Hypertension
Not Applicable
Completed
- Conditions
- Treatment-Resistant Hypertension
- Interventions
- Behavioral: Structured center-based lifestyle interventionBehavioral: Standard education and physician advice
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Duke University
- Target Recruit Count
- 140
- Registration Number
- NCT03001427
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Immunologic Signatures Following Surgery for Pancreatic Cancer
Completed
- Conditions
- Pancreatic CancerSurgery
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Duke University
- Target Recruit Count
- 33
- Registration Number
- NCT03001518
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Registry for Pancreatic Cancer
Withdrawn
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Duke University
- Registration Number
- NCT03001505
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking
Phase 4
Completed
- Conditions
- Smoking CessationAlcohol Drinking
- Interventions
- Other: Nicotine Replacement TherapyBehavioral: Cognitive Behavioral TreatmentBehavioral: Mobile Contingency ManagementBehavioral: Mobile Monitoring
- First Posted Date
- 2016-12-19
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Duke University
- Target Recruit Count
- 45
- Registration Number
- NCT02995915
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Longitudinal Outcomes in Hepatic Resection
Withdrawn
- Conditions
- Liver DiseasesSurgery
- First Posted Date
- 2016-12-19
- Last Posted Date
- 2018-07-31
- Lead Sponsor
- Duke University
- Registration Number
- NCT02997098
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors
Not Applicable
Completed
- Conditions
- Pressure Ulcer
- Interventions
- Other: 4 hour repositioningOther: 2 hour repositioningOther: 3 hour repositioning
- First Posted Date
- 2016-12-19
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- Duke University
- Target Recruit Count
- 2113
- Registration Number
- NCT02996331
- Locations
- 🇺🇸
Quinnipiac Valley Center, Wallingford, Connecticut, United States
Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys
Completed
- Conditions
- Air QualityCOPDRespiratory SymptomsAsthmaTobacco UseDisparities
- First Posted Date
- 2016-12-13
- Last Posted Date
- 2016-12-13
- Lead Sponsor
- Duke University
- Target Recruit Count
- 40690
- Registration Number
- NCT02991391
Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
Phase 2
Completed
- Conditions
- Chemo-radiation Induced Nausea and Vomiting
- Interventions
- First Posted Date
- 2016-12-13
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Duke University
- Target Recruit Count
- 48
- Registration Number
- NCT02991456
- Locations
- 🇺🇸
The Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina, United States